A Unique Solution for Patient Eligibility Review

Judi in Remote Monitoring and Medrio EDC Integration

Navigating the Post-Capture Era of Clinical Trials

Clinical-stage biotech combines Judi in Eligibility and Adjudication on pivotal Phase 2 CAR-T oncology trial

International biopharma sponsor and partner CRO maximize flexibility of Judi in DSMB for Phase 2 multinational clinical program

U.S.-based biopharma leverages scalability of Judi in Imaging on three concurrent pulmonary oncology trials

U.S.-based medical device sponsor and partner CRO leverage flexibility of Judi in DSMB for cardiovascular implant trial

Harnessing AI for Clinical Trial Workflow Management

European-based biopharma and partner CRO employ dynamic controls of Judi in Adjudication and Site & User Qualification for rare disease immunotherapy trial

European-based pharmaceutical company and CRO utilize dexterity of Judi in Eligibility on pivotal phase 3, novel psychedelic clinical program

Multinational biopharmaceutical company engages innovation of Judi in Adjudication for concurrent Phase 3 clinical trials with over 900 patients, and 150 endpoints

Global biopharma sponsor selects dynamic innovation of Judi in Imaging on critical Phase 3 Oncology trial with over 170 sites and 4000 endpoints

Prominent medical device company leverages the flexibility of Judi in Imaging and Eligibility on pivotal phase 3 medical implant trial

AG Mednet Receives Frost & Sullivan's 2023 Global Customer Value Leadership Award

Addressing Regulatory Challenges

Judi Accelerates Clinical Trials